Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vomiting 2Postoperative Nausea and Vomiting 1Neoplasms 1Nausea 1Hematologic Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × ramosetron × Clear all
NCT01788605 2014-12-08

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

The Catholic University of Korea

Phase 2 Unknown
65 enrolled
Other hematologic neoplasm

Vomiting, Hematologic Neoplasms

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown
41 enrolled

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡